LymeX Authorization Act
LymeX Authorization Act
Plain Language Summary
# LymeX Authorization Act Summary **What the Bill Does:** The LymeX Authorization Act (HR 7482) is a proposed federal law that would authorize funding and programs to address Lyme disease in the United States. While specific details aren't provided in the available information, bills with "authorization" in their name typically establish or expand federal programs and specify how much money can be spent on them. This bill appears to focus on combating Lyme disease, a tick-borne illness that affects thousands of Americans annually. **Who It Affects:** The bill would primarily affect people with Lyme disease or at risk of contracting it, as well as federal health agencies responsible for disease research, prevention, and treatment.
It may also impact state health departments and healthcare providers involved in Lyme disease management. **Current Status:** As of now, the bill is in committee, meaning it has been introduced in the House of Representatives but has not yet been voted on by the full chamber. It was sponsored by Representative Christopher H. Smith, a Republican from New Jersey. *Note: To understand the specific provisions and funding amounts proposed, you would need to review the full bill text on Congress.gov.*.
Latest Action
Referred to the House Committee on Energy and Commerce.